Agentix (AGTX) EBIT (QoQ) (2014 - 2026)
Agentix (AGTX) EBIT (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -75.93% |
| Mar 31, 2026 | 19.53% |
| Dec 31, 2025 | 45.20% |
| Sep 30, 2025 | 38.56% |
| Jun 30, 2025 | -16.40% |
| Mar 31, 2025 | -77.78% |
| Dec 31, 2024 | -4.09% |
| Sep 30, 2024 | 38.53% |
| Jun 30, 2024 | -697.43% |
| Mar 31, 2024 | 259.83% |
| Dec 31, 2023 | 95.51% |
| Sep 30, 2023 | 11.96% |
| Jun 30, 2023 | 6.52% |
| Mar 31, 2023 | -21.35% |
| Dec 31, 2022 | 16.66% |
| Sep 30, 2022 | -157.71% |
| Feb 28, 2022 | -1,109.80% |
| Nov 30, 2021 | 31.69% |
| Aug 31, 2021 | -40.90% |
| May 31, 2021 | 75.50% |